POLA1 Gene

Last updated on: 12.04.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The POLA1 gene (POLA1 stands for "DNA polymerase alpha 1, catalytic subunit") is a protein-coding gene, with the cytogenetic assignment: Xp22.11-p21.3.

The POLA1 gene encodes the catalytic subunit of DNA polymerase, which together with a regulatory and another two primase subunits forms the DNA polymerase alpha complex. This enzyme complex, which occurs in eukaryotes, is involved in the initiation of DNA replication. The DNA polymerase-alpha complex consists of 4 subunits: the catalytic subunit POLA1, the regulatory subunit POLA2 and the small and large primase subunits PRIM1 and PRIM2, respectively. Once the primase has generated the RNA primer, Pol alpha begins replication and extends the primer by about 20 nucleotides. The POLA1 catalytic subunit thus plays an essential role in the initiation of DNA replication.

Clinical pictureThis section has been translated automatically.

Diseases associated with POLA1 include:

  • Van Esch-O'driscoll syndrome (Van Esch-O'Driscoll syndrome (VEODS) is characterized by varying degrees of intellectual disability, moderate to severe short stature, microcephaly, hypogonadism, and various congenital malformations (Van Esch et al., 2019).

And

LiteratureThis section has been translated automatically.

  1. Ades LC et al (1993) An X-linked reticulate pigmentary disorder with systemic manifestations: report of a second family. Pediat Derm 10: 344-351.
  2. Anderson RC et al (2005) X-linked reticulate pigmentary disorder with systemic manifestations: report of a third family and literature review. Pediat. Derm. 22: 122-126.
  3. Partington MW et al (1989) Familial cutaneous amyloidosis with systemic manifestations in males. Am J Med Genet 10: 65-75.
  4. Partington MW et al (1989) X-linked cutaneous amyloidosis: further clinical and pathological observations. Am J Med Genet 32: 115-119.
  5. Starokadomskyy P et al (2016) DNA polymerase-alpha regulates the activation of type I interferons through cytosolic RNA:DNA synthesis. Nature Immun 17: 495-504.
  6. Starokadomskyy P et al (2019) NK cell defects in X-linked pigmentary reticulum disorder. JCI Insight 4:e125688.
  7. Van Esch H et al. (2019) Defective DNA polymerase alpha-primase leads to X-linked intellectual disability associated with severe growth retardation, microcephaly, and hypogonadism. Am. J. Hum. Genet104: 957-967-.

Last updated on: 12.04.2022